Try our Advanced Search for more refined results
Life Sciences - January, 2007
136 articles
- Court Rules In Pfizer's Favor In Norvasc Patent Case
- Express Scripts To Resubmit Antitrust Filing
- FDA Reveals Big Changes In Tracking Drug Safety
- Senate Bill Would Ban Authorized Generics
- Dr. Shielded From Wyeth's Bid To Compel Info
- Backdating Charges Surface In Caremark Row
- Group Opposes Caremark, Express Scripts Union
- Firm Names First African-American Dept. Head
- Judge Refuses To Toss Aredia Plaintiffs
- Punitive Damages To Proceed In Prempro Trial
- Court Blocks Israeli Co. From Suing Amgen
- Pfizer's Painkiller Class Action Grows
- DOJ: Roxane Bilked Medicare, Medicaid
- Merck Wins Stay In Colorado Vioxx Case
- Health Data Collectors Attack Prescription Law
- Glaxo Refutes Claims It Hid Teen Suicide Link
- Wyeth Suffers Setback In Prempro Trial
- Amid Uproar, Novartis Files Gleevec Appeal
- Thailand Breaks Patents For Plavix, HIV/AIDS Drug
- Wyeth Denied Summary Judgment
- FTC Takes Deeper Look At $919M Biotech Merger
- Skadden Lures Cadwalader Antitrust Trio
- Pfizer's Canadian Lipitor Patent Declared Invalid
- Apotex Seeks Approval For Generic Ulcer Medication
- Appeals Court Affirms Antitrust Dialysis Decision
- Bayer's Trasylol Woes Trigger First Liability Suit
- Lawmakers Scrutinize Express Scripts Bid
- Merck Accused Of Denying Overtime
- Class Denied In Paxil Case
- Teva Launches 18 Patent Suits
- Thailand Mulls Breaking Patents On Two Drugs
- Appeals Court Remands Syringe Patent Case
- Express Scripts Can Keep Lawyers, Says Judge
- SEC Warns Cardinal Health Executive
- Class Certifications Faced Challenges In 2006
- Court Shakes Head At Medtronic Whistleblower
- Remaining Claims Thrown Out in Alaris, ICU Case
- Lenders Object To Nellson's Extension Bid
- FTC's Antitrust Case Over Birth Control Continues
- Cell Therapeutics To Settle For $10.5M
- Canadian Court Gives Nod To Prepulsid Class Action
- E.U. Court Advisor Rejects Bid To Close Drug Loophole
- AAI Appoints First Director Of Legal Advocacy
- Judge To Consider Class In Pfizer's Neurontin Cases
- Bayer Shells Out More Over Baycol
- Barr Sued By Celgene Over Generic Thalomid
- Attorney Destroyed Evidence In Fen-Phen Case
- Plavix Makers Fight For Exclusivity
- Third Prempro Trial To Begin In Arkansas
- Woman Drops Vioxx Suit
- AIDS Group Sues Pfizer Over Viagra Ads
- Eli Lilly In Hot Seat Again Over Zyprexa
- Amgen Should Win Patent Suit, Analyst Says
- Judge Values Nellson Nutraceutical At $320M
- India's Patent Laws Fall Short, Report Claims
- Decision Showcases Debate Within Federal Circuit
- Novogen Settles Menopause Supplement Suit
- Jury Deadlocks In Two California Vioxx Cases
- Federal Circuit Affirms Ultracet Decision
- On Eve Of Plavix Trial, Apotex Suffers Another Blow
- Antitrust Watchdog Forces Drug Divestitures
- Looking East, U.S. Law Firms Boost India Practices
- Lawsuits Pile Up For Antipsychotic Drug
- Merck Case Threatens Patent Term Extensions
- Schering-Plough Sentenced In Medicaid Fraud Case
- Teva Sues Generic Zoloft Rivals
- Pfizer Sues IVAX To Protect Market For Detrol
- Ex-Milberg Weiss Antitrust Partners Join Pomerantz
- CEO On Trial In Biggest South Carolina Fraud Case
- Massive Medicaid Case To Stay In State Court
- Foley & Lardner Filed Patent Application Late: Suit
- University Says Inventor Was Left Off Hepatitis Patent
- For IPR In India, A Time Of Sea Change
- Senate Bill Targets Reverse Payments
- Angiotech, Boston Scientific Win Dutch Patent Case
- Former Head of U.N. Oil-For-Food Program Indicted
- Stryker Faces Class Action Over Pain-Relief Device
- U.S. Competition Watchdog Decries Drug Deals
- Canadian Pharmacists Protest U.S. Drug Exports
- U.K. Court Affirms Ruling Revoking Stent Patent
- Italian Company Wins Patent Decision Against Purdue
- Appeals Court Reawakens Vioxx Testing Campaign
- Appeals Court Upholds $41M Ruling Against Mary Kay
- "MedImmune" Ushers In New Era Of Patent Litigation
- Medicare Reform Faces Challenges, Rival Proposals
- Debate On Proposed Medicare Changes Heats Up
- Bayer, Novartis Near Settlement Over MS Drug
- Plaintiff Dismisses Chinese Vitamin C Antitrust Case
- Digene Files Patent Suit Against Third Wave
- Effects Of Proposed Medicare Changes Disputed
- Lilly To Take $495M Charge To Settle Zyprexa Suits
- FDA Seeks $87.4M Hike In Prescription Drug User Fees
- DNA Patent Suit Settled For $3.35M
- Indian Generics Companies Change Course
- Small Drug Sellers Seek Marketing Law Change
- Abbott Hit With Permanent Injunction
- High Court Shakes Head At Hytrin Settlement Case
- Drug Maker Drops Patent Appeal
- Ranbaxy Eyes Merck's Generics Unit
- Supreme Court Backhands Key Federal Circuit Test
- Two Suits Attempt To Derail CVS-Caremark Merger
- Impax Laboratories Reacts To SEC Suspension
- ArthroCare To Settle Patent Suit For $2.75M
- Doctor Withdraws Patent Suit For Pain Invention
- Congress Tackles Medicare Drug Plan
- Medtronic Faces More Suits Over Pacemaker Recall
- Novartis Case Tests India's IP Climate
- Novartis Sues To Reverse USPTO Judgment
- India Mulls Data Protection
- Caremark Nixes Bid, Avoids Antitrust Scrutiny
- Supreme Court Ruling Bolsters Licensee Rights
- Caltech Launches Suit Over Microsurgical Tools
- Sanofi-Aventis Sued By Reps For Overtime Pay
- New Bill Clears Path For $4 Generics
- Judge Calls Merck Subpoena "Abusive And Arrogant"
- Assaulted Women Sue Rite Aid For Negligence
- Appeals Court Affirms Abbott's Biaxin Injunction
- Abbott Facing Stent Injunction After French Ruling
- Federal Circuit Denies Ariad's Request
- Duane Morris Wants Another Trial Against McKesson
- Bayer, TrimSpa Settle With FTC Over Ads
- Eli Lilly Settles Zyprexa Claims
- Novartis Hits Par With Second Lotrel Suit
- Drug Innovation Stalls Despite R&D Spending: Report
- Mintz Levin Snares Health Care Partners For New York
- Patent Rule Changes: Preparing A Medtech Portfolio
- Abbott Defeated In HCV Patent Spat
- Law Firm Profile: Woodcock Washburn LLP
- Fulwider Pays $8M To Settle Misconduct Claims
- Synthes Sues Stryker Over Bone Plate Patent
- Abbott E-Mails Could Affect Patent Evergreening Suits
- Drug Makers Sued Over Cholesterol Drug
- Appeals Court Nixes Savient Injunction Bid
- Eli Lilly Scores In Zyprexa Patent Feud
- DNA Sequencing Rivals Head To Court
- Appeals Court Vacates Ventana Ruling